#United States #Dallas #Colossal Biosciences #Fish and Wildlife #BioVault

Groundbreaking BioVault Initiative for Endangered Species

In a historic collaboration, Colossal Biosciences, the world's pioneering de-extinction company, has joined forces with the U.S. Fish and Wildlife Service (USFWS) to implement a comprehensive initiative designed to protect and conserve every species currently listed under the Endangered Species Act (ESA). Officially announced on June 25, 2026, this innovative project aims to establish a genomic and biobanking archive, making strides toward biodiversity conservation on an unprecedented scale.

The BioVault initiative, part of Colossal's distributed network, plans to collect, sequence, and preserve living cells, reproductive tissues, and genomic material from over 2,300 threatened and endangered species. If successful, this endeavor could become one of the most extensive biodiversity preservation ventures ever undertaken in the United States. The genomic data produced through this partnership will be made accessible to the global scientific community, which is crucial for future conservation, recovery, and restoration efforts.

Secretary of the Interior Doug Burgum stated, "America leads the world when we embrace innovation and put our best minds to work solving big challenges. This collaboration merges the scientific expertise of the USFWS with private sector ingenuity to create tools that can help recover species and preserve vital genetic resources."

The partnership's primary objective is to establish a robust framework focused on preserving genetic diversity and enhancing scientific understanding of how genomic technologies can aid endangered species recovery. By exploring groundbreaking technologies, the initiative aims to contribute positively to the long-term sustainability of wildlife.

CEO and Co-Founder of Colossal Biosciences, Ben Lamm, emphasized the initiative's monumental scope. “Just as the Svalbard Global Seed Vault was created to safeguard the genetic diversity of our food supply, this partnership aims to protect the genetic diversity of life itself. Each species encompasses a library of evolutionary history. Once lost, that knowledge is irretrievable.”

Through this initiative, Colossal seeks to create an extensive living archive of Earth's biodiversity, dubbing it a modern-day Noah’s Ark constructed from DNA. The endeavor underlines a commitment to preserving not only the biological building blocks of our planet but also ensuring that future generations can learn, analyze, and restore these natural resources.

Colossal Biosciences operates a state-of-the-art infrastructure dedicated to conservation biobanking and genomics. Their BioVault facilities utilize cryopreservation techniques to store living cell lines, reproductive tissues, and high-quality genomic DNA from endangered species. This preserved biological material is essential for assisted reproduction, managing population genetics, and potentially restoring species in the event of extinction. Moreover, all genomic data created through this collaboration will be deposited in open-access repositories, empowering researchers and conservationists worldwide with the necessary tools to expedite recovery efforts, extending far beyond the capabilities of individual agencies.

The long-term vision encompasses complete biobanking and genomic coverage of all ESA-listed species. Currently, priority sampling and sequencing processes are already underway, ensuring that critical genomic data is integrated into federal recovery strategies. This approach paves the way for efficient data sharing between researchers, wildlife managers, and conservation organizations, fostering collaboration and innovation to enhance species recovery.

U.S. Fish and Wildlife Service Director Brian Nesvik stated, "As biodiversity faces increasing threats globally, we must apply the best available science to protect America's natural heritage. This collaboration propels our comprehension of how biobanking and genomics can enrich existing conservation tools and aid imperiled species recovery."

Matt James, Chief Animal Officer at Colossal Biosciences, expressed optimism about the transformative potential of this initiative. “This marks a new era for conservation in the United States. We are building a permanent genetic record for our most vulnerable species before they vanish. Future conservationists will inherit not merely notes but genomic tools pivotal for understanding, protecting, and restoring biodiversity.”

In essence, the BioVault initiative represents a crucial investment in wildlife conservation and genetic diversity preservation. It signifies a shared responsibility to protect our planet and its inhabitants, safeguarding biodiversity for future generations. The Memorandum of Understanding reflects a mutual commitment to the principles of conservation science while remaining flexible for future funded projects and collaborations.

About Colossal Biosciences
Founded by technology entrepreneur Ben Lamm and renowned geneticist George Church, Colossal Biosciences is leveraging CRISPR technology for species de-extinction. The company's mission includes the development of revolutionary technologies aimed at restoring endangered ecosystems, marking a commitment to Earth's ecological and biological future.

About the U.S. Fish and Wildlife Service
The USFWS collaborates with various partners to conserve, protect, and enhance wildlife and their habitats throughout the United States. By incorporating science-based approaches and restoration efforts, the Service strives to safeguard biodiversity for future generations.